The clinical impact of SGLT2 inhibitor cardiovascular outcomes trials

2 September 2019 (13:10 - 13:25)
Organised by:
Congress Presentation Part of: Spotlight on the effects of SGLT2 inhibition in heart failure (EBAC accredited) Treatment ESC Premium Access ESC Congress 2019

About the speaker

Photo

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

4 More presentations in this session

Presentation thumbnail
Professor F. Ruschitzka (Zurich, CH)
Presentation thumbnail
Professor F. Ruschitzka (Zurich, CH) Doctor M. Bonaca (Aurora, US) Professor S. Verma (Toronto, CA) Doctor M. Kosiborod (Kansas City, US)

The Event

Event poster

ESC Congress 2019

2 September 2019 13:10 CET